Picroside II protects rat kidney against ischemia/reperfusion-induced oxidative stress and inflammation by the TLR4/NF-κB pathway. 2015

Lei Wang, and Xiu-Heng Liu, and Hui Chen, and Zhi-Yuan Chen, and Xiao-Dong Weng, and Tao Qiu, and Lin Liu
Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.

Picroside II possesses a wide range of pharmacological effects and has been demonstrated to ameliorate cerebral ischemia and reperfusion (I/R) injury. However, its effects on renal I/R injury remain unclear. In the present study, the role of picroside II in attenuating oxidative stress and the inflammatory response in a rat model of renal I/R injury was investigated. Sprague Dawley rats were subjected to 45 min of ischemia followed by 24 h of reperfusion. Prior to reperfusion, the rats were treated with picroside II or an equal volume of phosphate-buffered saline. Renal function and histological changes were compared and the relevant parameters of oxidative stress and inflammation were detected. The expression of toll-like receptor 4 (TLR4) and nuclear factor κB (NF-κB; p65) were assessed by immunohistochemistry and western blotting. It was observed that renal function was significantly improved by treatment with picroside II. Morphological analysis indicated that picroside II clearly reduced tissue damage and the expression of TLR4 and NF-κB. Reverse transcription-quantitative polymerase chain reaction demonstrated that picroside II inhibited the increase of tumor necrosis factor (TNF)-α, interleukin (IL)-1β and intercellular adhesion molecule (ICAM)-1 expression induced by I/R injury. Western blot analysis indicated that the expression levels of TLR4 and NF-κB were significantly downregulated in the picroside II group compared with those in the I/R group. These results indicate that picroside II treatment suppressed the TLR4/NF-κB signaling pathway, protecting renal tissue against I/R-induced oxidative stress and inflammatory response.

UI MeSH Term Description Entries

Related Publications

Lei Wang, and Xiu-Heng Liu, and Hui Chen, and Zhi-Yuan Chen, and Xiao-Dong Weng, and Tao Qiu, and Lin Liu
June 2017, Inflammation,
Lei Wang, and Xiu-Heng Liu, and Hui Chen, and Zhi-Yuan Chen, and Xiao-Dong Weng, and Tao Qiu, and Lin Liu
September 2017, Oncotarget,
Lei Wang, and Xiu-Heng Liu, and Hui Chen, and Zhi-Yuan Chen, and Xiao-Dong Weng, and Tao Qiu, and Lin Liu
November 2019, The Kaohsiung journal of medical sciences,
Lei Wang, and Xiu-Heng Liu, and Hui Chen, and Zhi-Yuan Chen, and Xiao-Dong Weng, and Tao Qiu, and Lin Liu
January 2015, Acta cirurgica brasileira,
Lei Wang, and Xiu-Heng Liu, and Hui Chen, and Zhi-Yuan Chen, and Xiao-Dong Weng, and Tao Qiu, and Lin Liu
March 2018, Journal of cellular physiology,
Lei Wang, and Xiu-Heng Liu, and Hui Chen, and Zhi-Yuan Chen, and Xiao-Dong Weng, and Tao Qiu, and Lin Liu
September 2018, European journal of pharmacology,
Lei Wang, and Xiu-Heng Liu, and Hui Chen, and Zhi-Yuan Chen, and Xiao-Dong Weng, and Tao Qiu, and Lin Liu
April 2016, Environmental toxicology and pharmacology,
Lei Wang, and Xiu-Heng Liu, and Hui Chen, and Zhi-Yuan Chen, and Xiao-Dong Weng, and Tao Qiu, and Lin Liu
May 2014, Environmental toxicology and pharmacology,
Lei Wang, and Xiu-Heng Liu, and Hui Chen, and Zhi-Yuan Chen, and Xiao-Dong Weng, and Tao Qiu, and Lin Liu
July 2019, Experimental and therapeutic medicine,
Lei Wang, and Xiu-Heng Liu, and Hui Chen, and Zhi-Yuan Chen, and Xiao-Dong Weng, and Tao Qiu, and Lin Liu
January 2018, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology,
Copied contents to your clipboard!